CHART Thread, page-7

Agree with your investment thesis here but not sure about you figures. You look to be interchanging between revenue and cash receipts.

Sept Quarter 2018 sales revenue was $1.1mil. Cash receipts were $830k

I would expect revenue for Dec Quarter to be getting closer to being in range of $1.3mil to $1.5mil. Receipts difficult to estimate but obviously the revenue booked in Sept that wasn't receipted will have been received in Dec quarter and so on for Dec quarter into this one.

The $400k R&D rebate also hit the bank account in Dec quarter. This gets recognised as "revenue" technically but doesn't form part of my above estimated range.

Agree that SP3 appears undervalued and out of favour. Looking forward to an update.